GlassScriptPhysician profile
Suzanne M Surovec
NPI 1861664385
$1,933.52
in general payments reported to CMS, 2019-2025
11 companies · $652 in 2025
The $652 reported for 2025 was more than what 91% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $214 · 2022: $575 · 2023: $300 · 2024: $192 · 2025: $652.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,023 · Education: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,023.15 |
| Education | $120.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $355.89 | 2021-2025 | Jemperli |
| Merck Sharp & Dohme LLC | $267.63 | 2022-2025 | Keytruda, Lynparza |
| Astrazeneca Pharmaceuticals LP | $245.52 | 2025 | Lynparza |
| Genmab U.S., INC. | $233.06 | 2021-2025 | Tivdak |
| Seagen INC. | $160.00 | 2023-2025 | Tivdak |
| Allergan, INC. | $157.91 | 2022 | |
| Caris Mpi, INC. | $133.08 | 2025 | Mi Cancer Seek |
| Abbvie INC. | $121.87 | 2024-2025 | |
| Eisai INC. | $117.29 | 2022 | |
| Astellas Pharma US INC | $100.44 | 2024 | Veozah |
| Immunogen, INC. | $40.83 | 2023 | Elahere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Surovec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.